Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis

Condition:   Relapsing Remitting Multiple SclerosisInterventions:   Drug: BG00002 (natalizumab);   Drug: interferon beta-1a;   Drug: glatiramer acetateSponsors:   Biogen Idec;   Elan PharmaceuticalsTerminated - verified July 2014

Source: ClinicalTrials.gov - January 26, 2010 Category: Research Source Type: clinical trials